Skip to content
Delayed ~15 min

EPC EDGEWELL PERSONAL CARE

Consumer Discretionary · Russell 2000

Next earnings: Thu 12 Nov 2026 · before market open

What 8 analyst firms say about EDGEWELL PERSONAL CARE: their latest ratings, price targets and how far the stock is from them. How it works

27.99 USD−0.57 (−2.00%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+12.5%to the avg target 31.50 USD+3.51 USD
Buy 3 · Hold 3 · Sell 0

6 rated views · 8 analyst/firm records · 8 firms

Latest report15 Oct 2026avg report date 23 Aug
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8032
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8049

Recent analyst activity · last 90 days

Our tracked history has 3 reports on EPC from 3 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 1 lowered it and 1 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: UBS lowered its target from $32.00 (set 6 Aug 2026) to $30.00 on 15 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BarclaysLauren LiebermanHold7 Aug 202629.00 USD
Canaccord GenuitySusan AndersonBuy7 Jul 202634.00 USD
Morgan StanleyDara Mohsenian—6 Aug 202631.00 USD
RBC Capital MarketsNik ModiBuy6 Aug 202635.00 USD
UBSPeter GromHold15 Oct 202630.00 USD
Weiss RatingsUnnamed analyst—25 Aug 2026—
Wells FargoChris CareyBuy5 Oct 202630.00 USD
Data feed RESEARCHResearch TeamHold13 Apr 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.